WallStSmart

General Motors Company (GM)vsWest Pharmaceutical Services Inc (WST)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

General Motors Company generates 5919% more annual revenue ($185.02B vs $3.07B). GM leads profitability with a 146.0% profit margin vs 16.1%. WST appears more attractively valued with a PEG of 2.89. WST earns a higher WallStSmart Score of 55/100 (C-).

GM

Hold

44

out of 100

Grade: D

Growth: 3.3Profit: 6.0Value: 4.7Quality: 4.3
Piotroski: 3/9Altman Z: 1.20

WST

Buy

55

out of 100

Grade: C-

Growth: 4.7Profit: 8.0Value: 4.7Quality: 7.3
Piotroski: 5/9Altman Z: 4.91
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

GMSignificantly Overvalued (-258.9%)

Margin of Safety

-258.9%

Fair Value

$22.24

Current Price

$76.57

$54.33 premium

UndervaluedFair: $22.24Overvalued
WSTSignificantly Overvalued (-256.8%)

Margin of Safety

-256.8%

Fair Value

$68.99

Current Price

$245.27

$176.28 premium

UndervaluedFair: $68.99Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

GM4 strengths · Avg: 9.3/10
Price/BookValuation
1.1x10/10

Reasonable price relative to book value

Profit MarginProfitability
146.0%10/10

Keeps 146 of every $100 in revenue as profit

Market CapQuality
$67.92B9/10

Large-cap with strong market position

Free Cash FlowQuality
$5.68B8/10

Generating 5.7B in free cash flow

WST2 strengths · Avg: 9.0/10
Altman Z-ScoreHealth
4.9110/10

Safe zone — low bankruptcy risk

Operating MarginProfitability
21.6%8/10

Strong operational efficiency at 21.6%

Areas to Watch

GM4 concerns · Avg: 2.5/10
Return on EquityProfitability
4.3%3/10

ROE of 4.3% — below average capital efficiency

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

PEG RatioValuation
3.312/10

Expensive relative to growth rate

Revenue GrowthGrowth
-5.1%2/10

Revenue declined 5.1%

WST3 concerns · Avg: 3.3/10
P/E RatioValuation
36.1x4/10

Premium valuation, high expectations priced in

EPS GrowthGrowth
2.1%4/10

2.1% earnings growth

PEG RatioValuation
2.892/10

Expensive relative to growth rate

Comparative Analysis Report

WallStSmart Research

Bull Case : GM

The strongest argument for GM centers on Price/Book, Profit Margin, Market Cap. Profitability is solid with margins at 146.0% and operating margin at 6.5%.

Bull Case : WST

The strongest argument for WST centers on Altman Z-Score, Operating Margin. Profitability is solid with margins at 16.1% and operating margin at 21.6%.

Bear Case : GM

The primary concerns for GM are Return on Equity, Piotroski F-Score, PEG Ratio.

Bear Case : WST

The primary concerns for WST are P/E Ratio, EPS Growth, PEG Ratio.

Key Dynamics to Monitor

GM profiles as a declining stock while WST is a mature play — different risk/reward profiles.

GM carries more volatility with a beta of 1.36 — expect wider price swings.

WST is growing revenue faster at 7.5% — sustainability is the question.

GM generates stronger free cash flow (5.7B), providing more financial flexibility.

Bottom Line

WST scores higher overall (55/100 vs 44/100), backed by strong 16.1% margins. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

General Motors Company

CONSUMER CYCLICAL · AUTO MANUFACTURERS · USA

General Motors Company (GM) is an American multinational corporation headquartered in Detroit, Michigan that designs, manufactures, markets, and distributes vehicles and vehicle parts, and sells financial services, with global headquarters in Detroit's Renaissance Center.

West Pharmaceutical Services Inc

HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · USA

West Pharmaceutical Services, Inc. is a designer and manufacturer of injectable pharmaceutical packaging and delivery systems. The company is headquartered in Exton, Pennsylvania.

Want to dig deeper into these stocks?